COVID-19-Associated Liver Injury. [Review]

MedStar author(s):
Citation: Hepatic Medicine Evidence and Research. 15:1-9, 2023.PMID: 36852138Department: Internal Medicine Residency | MedStar Georgetown University Hospital/MedStar Washington Hospital CenterForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewYear: 2023ISSN:
  • 1179-1535
Name of journal: Hepatic medicine : evidence and researchAbstract: This review analyzes data regarding liver injury associated with COVID-19 infection. We discuss reported effects on the liver from both COVID-19 and COVID-19 treatment as well as pathophysiology, review the potential role of drug-induced liver injury as an etiology of COVID-19-associated liver injury, and touch on other reports of significant outcomes including COVID-19 cholangiopathy and autoimmune hepatitis. Finally, we review the implications of COVID-19 infection in liver transplant recipients. Copyright © 2023 Gildea et al.All authors: Gildea DT, Woo SM, O'Connor CE, Rangnekar ASFiscal year: FY2023Digital Object Identifier: ORCID: Date added to catalog: 2023-04-11
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article Available

This review analyzes data regarding liver injury associated with COVID-19 infection. We discuss reported effects on the liver from both COVID-19 and COVID-19 treatment as well as pathophysiology, review the potential role of drug-induced liver injury as an etiology of COVID-19-associated liver injury, and touch on other reports of significant outcomes including COVID-19 cholangiopathy and autoimmune hepatitis. Finally, we review the implications of COVID-19 infection in liver transplant recipients. Copyright © 2023 Gildea et al.

English

Powered by Koha